- Advertisement -
A new antibody therapy developed at Stanford Medicine has shown that it can prepare patients for stem cell transplants without the need for toxic chemotherapy or radiation, according to results from a phase 1 clinical trial.
The study focused on patients with Fanconi anemia, a rare genetic…
